FGF5 and hepatocellular carcinoma: Exosomal miR-9-3p targets the expression of fibroblast growth factor 5 (FGF5) to suppress HCC cell proliferation and the activation of the extracellular signal-regulated protein kinase1 and 2(ERK1/2) signaling pathway.